Your browser doesn't support javascript.
loading
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.
Dragomir, Mihnea P; Fuentes-Mattei, Enrique; Winkle, Melanie; Okubo, Keishi; Bayraktar, Recep; Knutsen, Erik; Qdaisat, Aiham; Chen, Meng; Li, Yongfeng; Shimizu, Masayoshi; Pang, Lan; Liu, Kevin; Liu, Xiuping; Anfossi, Simone; Zhang, Huanyu; Koch, Ines; Tran, Anh M; Mohapatra, Swati; Ton, Anh; Kaplan, Mecit; Anderson, Matthew W; Rothfuss, Spencer J; Silasi, Robert; Keshari, Ravi S; Ferracin, Manuela; Ivan, Cristina; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Georgescu, Constantin; Banerjee, Pinaki P; Basar, Rafet; Li, Ziyi; Horst, David; Vasilescu, Catalin; Bertilaccio, Maria Teresa S; Rezvani, Katayoun; Lupu, Florea; Yeung, Sai-Ching; Calin, George A.
Afiliación
  • Dragomir MP; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Fuentes-Mattei E; Department of Surgery, Fundeni Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Winkle M; Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Okubo K; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bayraktar R; Berlin Institute of Health (BIH), Berlin, Germany.
  • Knutsen E; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Qdaisat A; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Chen M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Li Y; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Shimizu M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Pang L; Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.
  • Liu K; Department of Emergency Medicine, The University of Texas MDACC, Houston, Texas, USA.
  • Liu X; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Anfossi S; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Zhang H; Department of Breast Surgery, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Science; Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Koch I; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Tran AM; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Mohapatra S; Department of Radiation Physics, The University of Texas MDACC, Houston, Texas, USA.
  • Ton A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Kaplan M; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Anderson MW; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Rothfuss SJ; Department of Pediatric Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Silasi R; Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Keshari RS; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Ferracin M; Baylor College of Medicine, Graduate School of Biomedical Sciences, Houston, Texas, USA.
  • Ivan C; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Rodriguez-Aguayo C; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Lopez-Berestein G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MDACC, Houston, Texas, USA.
  • Georgescu C; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Banerjee PP; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas, USA.
  • Basar R; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Li Z; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Horst D; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Vasilescu C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Bertilaccio MTS; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Rezvani K; Center for RNA Interference and Non-coding RNAs, The University of Texas MDACC, Houston, Texas, USA.
  • Lupu F; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.
  • Yeung SC; Center for RNA Interference and Non-coding RNAs, The University of Texas MDACC, Houston, Texas, USA.
  • Calin GA; Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
J Clin Invest ; 133(14)2023 07 17.
Article en En | MEDLINE | ID: mdl-37261908
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / MicroARNs Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / MicroARNs Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos